Cabaletta Bio (CABA) Current Assets (2018 - 2026)
Cabaletta Bio (CABA) posted quarterly Current Assets of $138.9 million for Q4 2025, down 16.68% year-over-year from $166.7 million in Q4 2024, and down 15.61% quarter-over-quarter from $164.6 million in Q3 2025.
Cabaletta Bio (CABA) Current Assets (2018 - 2026) Analysis & Trends
Cabaletta Bio's Current Assets history runs 8 years deep, the most recent figure standing at $138.9 million for Q4 2025.
- In Q4 2025, Current Assets fell 16.68% year-over-year to $138.9 million; the TTM figure through Dec 2025 stood at $138.9 million (down 16.68% YoY), while the FY2025 annual figure was $138.9 million, down 16.68% from the prior year.
- Current Assets for Q4 2025 stood at $138.9 million, down from $164.6 million in the prior quarter.
- The five-year high for Current Assets was $244.5 million in Q4 2023, with the low at $88.2 million in Q3 2022.
- The 5-year median for Current Assets is $136.7 million (2025), against an average of $148.5 million.
- The sharpest annual moves came in 2024 and 2025: Current Assets soared 137.62% in 2024, then plunged 40.83% in 2025.
- Cabaletta Bio's Current Assets stood at $124.5 million in 2021, then declined by 12.61% to $108.8 million in 2022, then surged by 124.64% to $244.5 million in 2023, then tumbled by 31.83% to $166.7 million in 2024, then slipped by 16.68% to $138.9 million in 2025.
- Business Quant data shows CABA's Current Assets at $138.9 million in Q4 2025, $164.6 million in Q3 2025, and $198.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | 231.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 231.03 Mn |
| Dec 31, 2025 | 138.87 Mn |
| Sep 30, 2025 | 164.56 Mn |
| Jun 30, 2025 | 198.41 Mn |
| Mar 31, 2025 | 134.60 Mn |
| Dec 31, 2024 | 166.68 Mn |
| Sep 30, 2024 | 185.52 Mn |
| Jun 30, 2024 | 206.26 Mn |
| Mar 31, 2024 | 227.48 Mn |
| Dec 31, 2023 | 244.49 Mn |
| Sep 30, 2023 | 166.18 Mn |
| Jun 30, 2023 | 177.57 Mn |
| Mar 31, 2023 | 95.73 Mn |
| Dec 31, 2022 | 108.83 Mn |
| Sep 30, 2022 | 88.18 Mn |
| Jun 30, 2022 | 98.75 Mn |
| Mar 31, 2022 | 111.44 Mn |
| Dec 31, 2021 | 124.54 Mn |
| Sep 30, 2021 | 120.85 Mn |
| Jun 30, 2021 | 105.02 Mn |